Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits.

Bodin K, Ellmerich S, Kahan MC, Tennent GA, Loesch A, Gilbertson JA, Hutchinson WL, Mangione PP, Gallimore JR, Millar DJ, Minogue S, Dhillon AP, Taylor GW, Bradwell AR, Petrie A, Gillmore JD, Bellotti V, Botto M, Hawkins PN, Pepys MB.

Nature. 2010 Nov 4;468(7320):93-7. doi: 10.1038/nature09494. Epub 2010 Oct 20.

2.

Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE-/- mice.

Tennent GA, Hutchinson WL, Kahan MC, Hirschfield GM, Gallimore JR, Lewin J, Sabin CA, Dhillon AP, Pepys MB.

Atherosclerosis. 2008 Jan;196(1):248-55. Epub 2007 Jun 22.

PMID:
17588586
3.

Targeting C-reactive protein for the treatment of cardiovascular disease.

Pepys MB, Hirschfield GM, Tennent GA, Gallimore JR, Kahan MC, Bellotti V, Hawkins PN, Myers RM, Smith MD, Polara A, Cobb AJ, Ley SV, Aquilina JA, Robinson CV, Sharif I, Gray GA, Sabin CA, Jenvey MC, Kolstoe SE, Thompson D, Wood SP.

Nature. 2006 Apr 27;440(7088):1217-21.

PMID:
16642000
4.

Human serum amyloid P component protects against Escherichia coli O157:H7 Shiga toxin 2 in vivo: therapeutic implications for hemolytic-uremic syndrome.

Armstrong GD, Mulvey GL, Marcato P, Griener TP, Kahan MC, Tennent GA, Sabin CA, Chart H, Pepys MB.

J Infect Dis. 2006 Apr 15;193(8):1120-4. Epub 2006 Mar 13.

PMID:
16544252
5.

Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself.

Pepys MB, Hawkins PN, Kahan MC, Tennent GA, Gallimore JR, Graham D, Sabin CA, Zychlinsky A, de Diego J.

Circ Res. 2005 Nov 25;97(11):e97-103. Epub 2005 Oct 27.

6.

Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.

Hirschfield GM, Gallimore JR, Kahan MC, Hutchinson WL, Sabin CA, Benson GM, Dhillon AP, Tennent GA, Pepys MB.

Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8309-14. Epub 2005 May 26.

7.

Human C-reactive protein does not protect against acute lipopolysaccharide challenge in mice.

Hirschfield GM, Herbert J, Kahan MC, Pepys MB.

J Immunol. 2003 Dec 1;171(11):6046-51.

8.

Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2.

Cohen SB, Crawley JB, Kahan MC, Feldmann M, Foxwell BM.

Immunology. 1997 Sep;92(1):1-5.

9.

Flow cytometric analysis and sorting of HLA-DR+CD1+ Langerhans cells.

Ashworth J, Kahan MC, Breathnach SM.

Br J Dermatol. 1989 Jul;121(1):11-8.

PMID:
2474321
12.
13.

Lymphocyte capping in Duchenne muscular dystrophy.

Stern CM, Kahan MC, Dubowitz V.

Lancet. 1979 Jun 16;1(8129):1300. No abstract available.

PMID:
87766

Supplemental Content

Loading ...
Support Center